FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 304:1067-1070 April 30, 1981 Number 18 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We studied 29 patients with malignant hypertension and 28 patients with the syndrome of inappropriate antidiuretic hormone secretion to assess the relation of plasma vasopressin to blood pressure in states of acute and chronic vasopressin excess. In the patients with malignant hypertension, vasopressin levels were elevated (13 +/- 2 pg per milliliter. [+/- S.E.M.]) but did not correlate with arterial pressure; however, in normal volunteers, blood pressure did not rise when vasopressin was increased beyond these levels through infusion of the peptide. In the patients with inappropriate antidiuretic hormone secretion, blood pressure was not elevated, but vasopressin was raised (39 +/- 7 pg per milliliter) and did not correlate with systolic or diastolic pressure. These data do not support the concept that an acute or chronic excess of vasopressin makes an important contribution to the regulation of blood pressure.

This article has been cited by other articles:

• Tiwari, S., Packer, R. K., Hu, X., Sugimura, Y., Verbalis, J. G., Ecelbarger, C. A. (2006). Increased renal {alpha}-ENaC and NCC abundance and elevated blood pressure are independent of hyperaldosteronism in vasopressin escape. Am. J. Physiol. Renal Physiol. 291: F49-F57 [Abstract] [Full Text]  
• Sharma, R. M., Setlur, R. (2005). Vasopressin in Hemorrhagic Shock. Anesth. Analg. 101: 833-834 [Abstract] [Full Text]  
• Song, J., Hu, X., Khan, O., Tian, Y., Verbalis, J. G., Ecelbarger, C. A. (2004). Increased blood pressure, aldosterone activity, and regional differences in renal ENaC protein during vasopressin escape. Am. J. Physiol. Renal Physiol. 287: F1076-F1083 [Abstract] [Full Text]  
• Morales, D. L.S., Garrido, M. J., Madigan, J. D., Helman, D. N., Faber, J., Williams, M. R., Landry, D. W., Oz, M. C. (2003). A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann. Thorac. Surg. 75: 926-930 [Abstract] [Full Text]  
• Landry, D. W., Oliver, J. A. (2001). The Pathogenesis of Vasodilatory Shock. NEJM 345: 588-595 [Full Text]  
• Morales, D. L.S., Gregg, D., Helman, D. N., Williams, M. R., Naka, Y., Landry, D. W., Oz, M. C. (2000). Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann. Thorac. Surg. 69: 102-106 [Abstract] [Full Text]  
• Morales, D., Madigan, J., Cullinane, S., Chen, J., Heath, M., Oz, M., Oliver, J. A., Landry, D. W. (1999). Reversal by Vasopressin of Intractable Hypotension in the Late Phase of Hemorrhagic Shock. Circulation 100: 226-229 [Abstract] [Full Text]  
• Grant, P., Wiles, P. (1991). The role of 8-arginine vasopressin (antidiuretic hormone) in vascular homeostasis. Vasc Med 2: 85-94  
• Blessing, W., Sved, A., Reis, D. (1982). Destruction of noradrenergic neurons in rabbit brainstem elevates plasma vasopressin, causing hypertension. Science 217: 661-663 [Abstract]